Epilepsy Drugs Market Scope And Analysis

  • Report Code : TIPRE00024323
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 139
Buy Now

Epilepsy Drugs Market Analysis and Growth - 2031

Buy Now


Epilepsy Drugs Market Report Scope

Report Attribute Details
Market size in 2022 US$ 7.7 Billion
Market Size by 2030 US$ 10.7 Billion
Global CAGR (2022 - 2030) 4.1%
Historical Data 2020-2021
Forecast period 2022-2030
Segments Covered By Treatment
  • First-Generation Anti-Epileptics
  • Second Generation Anti-Epileptics
  • Third Generation Anti-Epileptics
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • UCB SA
  • Novartis AG
  • Pfizer
  • GSK
  • Abbott
  • Sanofi
  • Sumito Pharma Company
  • Teva Pharmaceuticals
  • Catalyst Pharmaceuticals
  • Alkem Laboratories